Induction of Neutralizing Immunity against SARS-CoV-2 Omicron Variant by COVID-19 Vaccine Boosters
Journal: Medical Journal of Clinical Trials & Case Studies (Vol.6, No. 2)Publication Date: 2022-03-08
Authors : Cheepsattayakorn A Cheepsattayakorn R; Siriwanarangsun P;
Page : 1-1
Keywords : ;
Abstract
The Omicron variant (BA.1/B.1.1.529) is characterized by mutation of an unusually high number, with 26 to 32 changes (up to 36 mutations) in the spike (S) glycoprotein, the key epitopes (target) of neutralizing antibodies [1-3].
Other Latest Articles
- The Modified Two-By-Two Fixed Orthodontic Appliance for Anterior Cross Bite in Primary Dentition: A Case Report
- Efficacy of Nasal Smear Eosinophil Count in Detecting Allergic Rhinitis in Children
- Unusual Penetrating, Retained Cardiac Intramural Foreign Body: Case Report
- DNA Contains Genetic Information that is Inherited by Descendants
- Assessment of Fatty Liver Diseases Based on Serum Ck- 18 Fragment, Gamma Glutamyl Transferase and Aspartate Aminotransfease /Alanine Aminotransferase Ratio
Last modified: 2023-07-19 20:00:46